Robin Kramer - Net Worth and Insider Trading

Robin Kramer Net Worth

The estimated net worth of Robin Kramer is at least $47,712 dollars as of 2023-03-31. Robin Kramer is the Sr VP Chief Accounting Officer of Hertz Global Holdings Inc and owns about 5,459 shares of Hertz Global Holdings Inc (HTZGQ) stock worth over $47,712. Details can be seen in Robin Kramer's Latest Holdings Summary section.

Transaction Summary of Robin Kramer


Robin Kramer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robin Kramer owns 5 companies in total, including Biogen Inc (BIIB) , Hertz Global Holdings Inc (HTZGQ) , and Herc Holdings Inc (HRI) among others .

Click here to see the complete history of Robin Kramer’s form 4 insider trades.

Insider Ownership Summary of Robin Kramer

Ticker Comapny Transaction Date Type of Owner
BIIB Biogen Inc 2018-11-19 VP & Chief Accounting Officer
HTZGQ Hertz Global Holdings Inc 2018-04-29 Sr VP Chief Accounting Officer
HRI Herc Holdings Inc 2014-05-16 Sr VP & ChiefAccountingOfficer
ARMP Armata Pharmaceuticals Inc 2020-12-08 director
HTZ Hertz Global Holdings Inc 2018-03-02 Sr. VP & Chief Acc Officer

Robin Kramer Latest Holdings Summary

Robin Kramer currently owns a total of 1 stock. Robin Kramer owns 5,459 shares of Hertz Global Holdings Inc (HTZGQ) as of March 8, 2018, with a value of $47,712.

Latest Holdings of Robin Kramer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HTZGQ Hertz Global Holdings Inc 2018-03-08 5,459 8.74 47,712

Holding Weightings of Robin Kramer

Robin Kramer Form 4 Trading Tracker

According to the SEC Form 4 filings, Robin Kramer has made a total of 0 transactions in Hertz Global Holdings Inc (HTZGQ) over the past 5 years. The most-recent trade in Hertz Global Holdings Inc is the sale of 5,450 shares on March 8, 2018, which brought Robin Kramer around $107,202.

Insider Trading History of Robin Kramer

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
Hertz Global Holdings Inc
Hertz Global Holdings Inc
Total 2
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robin Kramer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robin Kramer Ownership Network

Ownership Network List of Robin Kramer

No Data

Ownership Network Relation of Robin Kramer

Robin Kramer Owned Company Details

What does Biogen Inc do?

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.

Who are the key executives at Biogen Inc?

Robin Kramer is the VP & Chief Accounting Officer of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .

Biogen Inc (BIIB) Insider Trades Summary

Over the past 18 months, Robin Kramer made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .

In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.

Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.


Biogen Inc Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Robin Kramer Mailing Address

Above is the net worth, insider trading, and ownership report for Robin Kramer. You might contact Robin Kramer via mailing address: 999 Vanderbilt Beach Road, 3rd Floor, Naples Fl 34109.